Skip to content

A Clinical trial on the effectivenss of Homoeopathic treatment for viral encephalitis

Effectiveness of homeopathic medicines-vs-placebo as add on to institutional management protocol for viral encephalitis (VE) - A randomized, placebo controlled trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/04/006857
Enrollment
200
Registered
2016-04-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Viral encephalitis

Interventions

Intervention1: Standard Therapy + Homoeoapthic medicines : Indicated homoepathic Medicine will be given to the patient as per homoeoapthic principles Control Intervention1: Standard therapy + Placebo

Sponsors

Central Council for Research in Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Clinically, a fresh case of VE is defined as a person between the age of 6 months-18 Years, - acute onset of fever of - change in mental status (including symptoms such as confusion, disorientation, coma, or inability to talk) -AND/OR new onset of seizures with clear colour, normal to raised protein, normal sugar and pleocytosis with mononuclear dominance cell in CSF of children -Informed consent

Exclusion criteria

Exclusion criteria: -Simple febrile convulsion (single convulsion lasting 15 min who recovered consciousness within 60 min). -A firm diagnosis of tuberculous or bacterial meningitis based on examination of CSF specimen or imaging findings. -All types of encephalopathy (hepatic, enteric, uraemic, septic, toxic) cerebral malaria or neurocysticercosis. -Acute Disseminated encephalo Myelopathy. -Age less than 6 months and above 18 years -Any pre-existing known major illnesses

Design outcomes

Primary

MeasureTime frame
reduction in the mortality and disabilityTimepoint: 3 month, 2 year

Secondary

MeasureTime frame
The secondary end points will be to see: â?¢The time to resolution of fever â?¢Resumption of oral feeding â?¢Duration of seizures â?¢Duration of unconsciousness â?¢ Total duration of hospitalization â?¢Institutional cost of therapyTimepoint: 3 months, 2 year

Countries

India

Contacts

Public ContactDr Praveen Oberai

Central Council for Research in Homoeopathy

oberai.praveen@gmail.com09811952274

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026